TheraRadar
Data updated: Sep 20, 2026

HYDRALAZINE HYDROCHLORIDE · IVAX SUB TEVA PHARMS

Cardiovascular Approved 1953-01-15
45
Indications
--
Phase 3 Trials
73
Years on Market

HYDRALAZINE HYDROCHLORIDE Approval History

1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
412 FDA actions from 1974 to 2025
Jul 2025 ORIGINAL
Update
Jun 2025 ORIGINAL
Update
Apr 2025 SUPPL
Label · Labeling

What HYDRALAZINE HYDROCHLORIDE Treats

45 FDA approvals

Originally approved for its first indication in 1974 . Covers 45 distinct patient populations.

  • Other (45)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

HYDRALAZINE HYDROCHLORIDE FDA Label Details

Looking for the branded version?

APRESOLINE

Full clinical data, patents, trials, and competitive landscape for hydralazine hydrochloride.

See APRESOLINE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.